Elixinol Wellness Limited
ELLXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $7,665 | $8,184 | $6,772 | $4,814 |
| % Growth | -6.3% | 20.9% | 40.7% | – |
| Cost of Goods Sold | $5,013 | $4,958 | $4,356 | $5,485 |
| Gross Profit | $2,652 | $3,226 | $2,416 | -$671 |
| % Margin | 34.6% | 39.4% | 35.7% | -13.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,275 | $1,159 | $1,442 | $1,279 |
| SG&A Expenses | $5,019 | $3,491 | $4,381 | $2,225 |
| Sales & Mktg Exp. | $1,700 | $1,440 | $949 | $946 |
| Other Operating Expenses | $0 | $2,876 | $0 | $0 |
| Operating Expenses | $5,019 | $6,367 | $4,381 | $2,225 |
| Operating Income | -$2,367 | -$3,141 | -$1,965 | -$2,896 |
| % Margin | -30.9% | -38.4% | -29% | -60.2% |
| Other Income/Exp. Net | -$726 | $585 | -$790 | -$1,214 |
| Pre-Tax Income | -$3,093 | -$2,556 | -$2,755 | -$4,110 |
| Tax Expense | $0 | -$3,590 | $1 | $1 |
| Net Income | -$3,093 | $1,034 | -$2,756 | -$4,111 |
| % Margin | -40.4% | 12.6% | -40.7% | -85.4% |
| EPS | -0.014 | 0.006 | -0.003 | -0.005 |
| % Growth | -348.2% | 300% | 45.1% | – |
| EPS Diluted | -0.014 | 0.006 | -0.003 | -0.005 |
| Weighted Avg Shares Out | 222,166 | 154,552 | 984,637 | 813,521 |
| Weighted Avg Shares Out Dil | 222,156 | 154,552 | 997,921 | 813,521 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $7 | $23 | $73 |
| Interest Expense | $275 | $111 | $66 | $73 |
| Depreciation & Amortization | $379 | $274 | $537 | $333 |
| EBITDA | -$2,857 | -$2,140 | -$2,152 | -$3,704 |
| % Margin | -37.3% | -26.1% | -31.8% | -76.9% |